BiotechTube
Home/Restem/Rafael Gonzalez, PhD
RG

Rafael Gonzalez, PhD

Chief Development & Science Officer

Restem

Therapeutic Areas

Autoimmune DisordersNeurological DisordersAge-related Diseases

Restem Pipeline

DrugIndicationPhase
Restem-LIdiopathic Inflammatory Myopathy (IIM)Phase 2/3
Restem-x (aNK)Age-related Diseases / Cellular SenescenceUnknown

Leadership Team at Restem

AI
Andres Isaias
Chief Executive Officer
View full Restem profile